Literature DB >> 12521622

Concentrations of interleukins, interferon, and C-reactive protein in stable and unstable angina pectoris.

Haruyo Yamashita1, Kazunori Shimada, Eriko Seki, Hiroshi Mokuno, Hiroyuki Daida.   

Abstract

We analyzed the concentrations of interleukins (IL)-6, IL-10, IL-12, and IL-18, interferon (IFN)-gamma, and high-sensitivity C-reactive protein (hsCRP) in 40 patients with unstable angina (UAP), 39 patients with stable angina (SAP), and 52 age- and gender-matched controls. Compared with the control group, IL-12 concentrations were significantly higher in both the SAP and UAP groups, especially in the UAP group, and the IL-18 concentrations tended to be higher in the UAP group. Conversely, IL-10 concentrations were significantly lower in the SAP and UAP groups. Both IL-6 and hsCRP concentrations were significantly higher in the UAP group. The levels of hsCRP were positively correlated with inflammatory or proinflammatory cytokines (IL-6, IL-12, and IL-18), and negatively correlated with anti-inflammatory cytokine (IL-10). Moreover, the levels of IL-12 were positively correlated with IL-18, and negatively correlated with IL-10, and the results revealed the T-helper 1 dominant state. These results suggested that the inflammatory response was strongly associated with coronary atherosclerosis and angina pectoris, and that the T-helper 1 dominance may play an important role in these diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12521622     DOI: 10.1016/s0002-9149(02)03097-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

Review 1.  Helper T cells and atherosclerosis: the cytokine web.

Authors:  S G Baidya; Q-T Zeng
Journal:  Postgrad Med J       Date:  2005-12       Impact factor: 2.401

Review 2.  Stabilization of high-risk plaques.

Authors:  Kohei Takata; Satoshi Imaizumi; Bo Zhang; Shin-Ichiro Miura; Keijiro Saku
Journal:  Cardiovasc Diagn Ther       Date:  2016-08

3.  Hyperlipidemia Alters Regulatory T Cell Function and Promotes Resistance to Tolerance Induction Through Costimulatory Molecule Blockade.

Authors:  J Bagley; J Yuan; A Chandrakar; J Iacomini
Journal:  Am J Transplant       Date:  2015-06-16       Impact factor: 8.086

4.  Inflammatory cytokines imbalance in the very early phase of acute coronary syndrome: correlations with angiographic findings and in-hospital events.

Authors:  Natale Daniele Brunetti; Irene Munno; Pier Luigi Pellegrino; Vincenzo Ruggero; Michele Correale; Luisa De Gennaro; Andrea Cuculo; Erasmo Giulio Campanale; Matteo Di Biase
Journal:  Inflammation       Date:  2011-02       Impact factor: 4.092

5.  Effect of interleukin-2 level and genetic variants on coronary artery disease.

Authors:  Ru Ding; Wenwu Gao; David H Ostrodci; Zhiqing He; Yuanlin Song; Lan Ma; Chun Liang; Zonggui Wu
Journal:  Inflammation       Date:  2013-12       Impact factor: 4.092

6.  Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome.

Authors:  T Kilic; D Ural; E Ural; Z Yumuk; A Agacdiken; T Sahin; G Kahraman; G Kozdag; A Vural; B Komsuoglu
Journal:  Heart       Date:  2006-03-17       Impact factor: 5.994

7.  Cynical hostility and stimulated Th1 and Th2 cytokine production.

Authors:  Denise Janicki-Deverts; Sheldon Cohen; William J Doyle
Journal:  Brain Behav Immun       Date:  2009-07-30       Impact factor: 7.217

8.  Interleukin-10 concentration and coronary heart disease (CHD) event risk in the estrogen replacement and atherosclerosis (ERA) study.

Authors:  Susan G Lakoski; Yongmei Liu; K Bridget Brosnihan; David M Herrington
Journal:  Atherosclerosis       Date:  2007-08-13       Impact factor: 5.162

9.  Interleukin-22, a potent target for treatment of non-autoimmune diseases.

Authors:  Yue Zheng; Tong Li
Journal:  Hum Vaccin Immunother       Date:  2018-10-31       Impact factor: 3.452

Review 10.  CRP and the risk of atherosclerotic events.

Authors:  Paolo Calabrò; Enrica Golia; Edward T H Yeh
Journal:  Semin Immunopathol       Date:  2009-05-05       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.